Tocilizumab for AA Amyloidosis after Treatment of Multicentric Castleman Disease with Steroids, Chemotherapy and Rituximab for Over 20 Years

导出原文传递

翻译打印收藏纠错

作者： Iijima, Takashi ^[1] ; Hoshino, Junichi ; Suwabe, Tatsuya ; Sumida, Keiichi ; Mise, Koki ; Kawada, Masahiro ; Ueno, Toshiharu ; Hamanoue, Satoshi ; Hayami, Noriko ; Hiramatsu, Rikako ; Sawa, Naoki ; Takaichi, Kenmei ; Ubara, Yoshifumi

作者单位： Toranomon Hosp Kajigaya, Nephrol Ctr, Kajigaya, Japan ^[1]

关键词 multicentric Castleman disease humanized anti-IL-6 receptor antibody tocilizumab IL-6 rituximab

发布时间 2017-06-09

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Internal medicine.

2015年54卷24期

3215-3219页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Tocilizumab for AA Amyloidosis after Treatment of Multicentric Castleman Disease with Steroids, Chemotherapy and Rituximab for Over 20 Years

Internal medicine.

相似文献

Internal medicine.

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Tocilizumab for AA Amyloidosis after Treatment of Multicentric Castleman Disease with Steroids, Chemotherapy and Rituximab for Over 20 Years

Internal medicine.

相似文献

Internal medicine.

相关期刊

检索历史清除